Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective Cohort Study to Document the Immunization Status of MS Patients in Germany With Focus on Anti-SARS-CoV-2 Vaccination Response

NCT05197699 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT05197699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05197699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective Cohort Study to Document the Immunization Status of MS Patients in Germany With Focus on Anti-SARS-CoV-2 Vaccination Response
Lead sponsor
Biogen
Phase
Observational
Overall status
Terminated
Start date
July 1, 2021
Completion date
September 30, 2023
Enrollment
160 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis (ms)